MedTrace Logo

Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer

NCT04795063 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2021-03-12

No results posted yet for this study

Summary

To evaluate the clinical efficacy (safety, feasibility and long-term efficacy) of total robotic versus robotic assisted distal gastrectomy for patients with gastric cancer (cT1-4a, N0/+, M0).

Conditions

Interventions

PROCEDURE

Total Robotic Distal Gastrectomy

All the surgical procedures are performed using the robot system.

PROCEDURE

Robotic-Assisted Distal Gastrectomy

After finishing the lymphadenectomy, the digestive tract reconstruction is performed extracorporal.

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Chang-ming Huang, MD · Fujian Medical University Union Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2024-01-01
Completion
2027-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04795063 on ClinicalTrials.gov